Infographic

Key data on first-line treatment selection for dentistry teams

  • Instrument calibration
  • Assay reproducibility
  • Minimally invasive techniques
  • Combination therapy

Date Published:

In Partnership with:

AbbVie, Agilent

Register to Download

About this Infographic

Longitudinal data show that integrating quantitative measures reduces subjective bias, particularly in resource-constrained settings. In multidisciplinary settings, real-world registries complement randomized trial evidence, and this trend is expected to continue.

Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Longitudinal data show that pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups. Recent studies suggest that variability between operators remains a key limitation, as discussed in the accompanying commentary.

In routine practice, real-world registries complement randomized trial evidence, and this trend is expected to continue. In multidisciplinary settings, threshold harmonization is still an open question, pending validation in prospective studies. Across multiple cohorts, patient selection criteria deserve closer scrutiny, which has direct implications for daily practice.

Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups. Emerging evidence indicates that early intervention correlates with better long-term outcomes, although confirmatory data are still limited.

In routine practice, variability between operators remains a key limitation, as discussed in the accompanying commentary. In multidisciplinary settings, early intervention correlates with better long-term outcomes, although confirmatory data are still limited. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups. When protocols are compared, variability between operators remains a key limitation, pending validation in prospective studies.

References

  1. Meyer et al. Assay reproducibility. J Dentistry Res. 2024;22(11):858-1076.
  2. Haddad et al. High-throughput screening. J Dentistry Res. 2024;28(6):551-1040.
  3. Meyer et al. Sample preparation. J Dentistry Res. 2026;47(6):841-1074.